New York, October 03, 2014 -- Moody's Investors Service said that the ratings of Covidien International Finance S.A. (a subsidiary of parent holding company, Covidien plc) remain under review for upgrade following news that Medtronic, Inc. plans to alter its financing of its acquisition of Covidien plc. Moody's placed Medtronic's A2/Prime-1 ratings on review for downgrade following this news. Moody's anticipates that if Medtronic's ratings are downgraded, its long-term rating would not fall more than one or two notches.

Vollständigen Artikel bei Moodys lesen